R3 Vascular, Inc.

R3 Vascular Inc. is an early-stage medical device company specializing in advanced bioresorbable vascular scaffolds (BVS) for treating peripheral arterial disease, particularly below-the-knee (BTK) blockages in patients with chronic limb-threatening ischemia. The company's flagship product, MAGNITUDE® Drug-Eluting Bioresorbable Scaffold, features a sirolimus coating that provides anti-inflammatory effects and fully resorbs over time to support vessel healing. R3 Vascular leverages proprietary polymer engineering and a unique manufacturing process utilizing ultra-high molecular weight polylactic acid. The company has secured FDA Investigational Device Exemption approval for its pivotal ELITE-BTK clinical trial, demonstrating commitment to rigorous clinical validation. R3 Vascular targets interventional cardiologists and vascular surgeons seeking innovative solutions for complex peripheral vascular disease management with bioresorbable technology that supports long-term vessel remodeling and healing.